人民幣定價:32 元
定價
:NT$ 192 元優惠價
:87 折 167 元
絕版無法訂購
商品簡介
目次
相關商品
商品簡介
“精要速覽系列(Instant Notes Series)”叢書是國外教材“Best Seller”榜的上榜教材。該系列結構新穎,視角獨特;重點明確,脈絡分明;圖表簡明清晰;英文自然易懂,被國內多所重點院校選用作為雙語教材。先鋒版是繼“現代生物學精要速覽”之后推出的跨學科的升級版本。
本書是該系列中的《醫藥化學》分冊,全書共13章,綜合了化學、生物學和計算機科學的內容,扼要介紹了藥物設計與發現、新藥開發與應用、臨床試驗及專利申請等。本書是指導大學生快速掌握醫藥化學基礎知識的優秀教材,也是輔助教師授課的極佳教學參考書,同時可供相關專業的研究生參考。
目次
Abbreviations
Preface
About the author
Section A-The science of medicinal chemistry
A1 Introduction
A2 From concept to market
Section B-Drug targets
B1 Enzymes
B2 Receptors
B3 Carrier proteins
B4 Structural proteins
B5 Nucleic acids
B6 Lipids
B7 Carbohydrates
Section C-Pharmacokinetics
C1 Pharmacokinetics
C2 Drug absorption
C3 Drug distribution
C4 Drug metabolism
C5 Drug excretion
C6 Drug administration
C7 Drug dosing
Section D-Biological testing and bioassays
D1 Testing drugs
D2 Testing drugs in uitro
D3 Testing drugs in uiuo
Section E-Drug discovery
E1 The lead compound
E2 Natural sources of lead compounds
E3 Synthetic sources of lead compounds
Section F-Synthesis
F1 Synthetic considerations
F2 Stereochemistry
F3 Combinatorial synthesis
Section G-Structure-activity relationships
G1 Definition of structure-activity relationshiips
G2 Binding interactions
G3 Functional groups as binding groups
G4 The pharmacophore
G5 Quantitative structure-activity relationships
Section H-Target orientated drug design
H1 Aims of drug design
H2 Computer aided drug design
H3 Simplification of complex molecules
H4 Conformational restraint
H5 Extra binding interactions
H6 Enhancing existing binding interactions
Section I-Pharmacokinetic orientated drug design
I1 Drug solubility
I2 Drug stability
Section J-Patenting and manufacture
J1 Patenting and chemical development
J2 Optimization of reactions
J3 Scale-up issues
J4 Process development
J5 Specifications
Section K-Preclinical testing and clinical trials
K1 Toxicology
K2 Pharmacology and pharamceutical chemistry
K3 Drug metabolism studies
K4 Clinical trials
K5 Regulatory affairs
Section L-Case study:inhibitors of EGF-receptor kinase
L1 Epidermal growth factor receptor
L2 Testing procedures
L3 From lead compound to dianilino-phthalimides
L4 Modeling studies
L5 4-(Phenylamino)pyrrolopyrimidines
L6 Pyrazolopyrimidines
Section M-History of medicinal chemistry
M1 The age of herbs,potions and magic
M2 The nineteenth century
M3 A fledgling science(1900-1930)
M4 The dawn of the antibacterial age(1930-1945)
M5 The antibiotic age(1945-1970s)
M6 The age of reason (1970s to present)
Further reading
Index
Preface
About the author
Section A-The science of medicinal chemistry
A1 Introduction
A2 From concept to market
Section B-Drug targets
B1 Enzymes
B2 Receptors
B3 Carrier proteins
B4 Structural proteins
B5 Nucleic acids
B6 Lipids
B7 Carbohydrates
Section C-Pharmacokinetics
C1 Pharmacokinetics
C2 Drug absorption
C3 Drug distribution
C4 Drug metabolism
C5 Drug excretion
C6 Drug administration
C7 Drug dosing
Section D-Biological testing and bioassays
D1 Testing drugs
D2 Testing drugs in uitro
D3 Testing drugs in uiuo
Section E-Drug discovery
E1 The lead compound
E2 Natural sources of lead compounds
E3 Synthetic sources of lead compounds
Section F-Synthesis
F1 Synthetic considerations
F2 Stereochemistry
F3 Combinatorial synthesis
Section G-Structure-activity relationships
G1 Definition of structure-activity relationshiips
G2 Binding interactions
G3 Functional groups as binding groups
G4 The pharmacophore
G5 Quantitative structure-activity relationships
Section H-Target orientated drug design
H1 Aims of drug design
H2 Computer aided drug design
H3 Simplification of complex molecules
H4 Conformational restraint
H5 Extra binding interactions
H6 Enhancing existing binding interactions
Section I-Pharmacokinetic orientated drug design
I1 Drug solubility
I2 Drug stability
Section J-Patenting and manufacture
J1 Patenting and chemical development
J2 Optimization of reactions
J3 Scale-up issues
J4 Process development
J5 Specifications
Section K-Preclinical testing and clinical trials
K1 Toxicology
K2 Pharmacology and pharamceutical chemistry
K3 Drug metabolism studies
K4 Clinical trials
K5 Regulatory affairs
Section L-Case study:inhibitors of EGF-receptor kinase
L1 Epidermal growth factor receptor
L2 Testing procedures
L3 From lead compound to dianilino-phthalimides
L4 Modeling studies
L5 4-(Phenylamino)pyrrolopyrimidines
L6 Pyrazolopyrimidines
Section M-History of medicinal chemistry
M1 The age of herbs,potions and magic
M2 The nineteenth century
M3 A fledgling science(1900-1930)
M4 The dawn of the antibacterial age(1930-1945)
M5 The antibiotic age(1945-1970s)
M6 The age of reason (1970s to present)
Further reading
Index
主題書展
更多
主題書展
更多書展今日66折
您曾經瀏覽過的商品
購物須知
大陸出版品因裝訂品質及貨運條件與台灣出版品落差甚大,除封面破損、內頁脫落等較嚴重的狀態,其餘商品將正常出貨。
特別提醒:部分書籍附贈之內容(如音頻mp3或影片dvd等)已無實體光碟提供,需以QR CODE 連結至當地網站註冊“並通過驗證程序”,方可下載使用。
無現貨庫存之簡體書,將向海外調貨:
海外有庫存之書籍,等候約45個工作天;
海外無庫存之書籍,平均作業時間約60個工作天,然不保證確定可調到貨,尚請見諒。
為了保護您的權益,「三民網路書店」提供會員七日商品鑑賞期(收到商品為起始日)。
若要辦理退貨,請在商品鑑賞期內寄回,且商品必須是全新狀態與完整包裝(商品、附件、發票、隨貨贈品等)否則恕不接受退貨。